Delivery Order SPE2DB20D3104-SPE2DB24FV8Z0

Award Date 8/23/24
Potential Completion Date 8/26/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.68 firm-fixed-price delivery order is for the supply of 100 units of Methylphenidate ER 27 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methylphenidate ER 27 mg tablets, a generic drug used to treat attention deficit hyperactivity disorder (ADHD). The Firm Fixed Price contract has a ceiling value of $2,199.72 and runs through October 31, 2024. This award is a Delivery Order under an Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,733.00 delivery order is for the supply of 100 tablets of 27 mg extended-release methylphenidate, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,754.71 firm fixed-price delivery order is for the supply of 4563347377 - methylphenidate ER 54 mg tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides the Defense Logistics Agency (DLA) with 100 tablets of 36 mg Methylphenidate ER, a generic medication used to treat attention-deficit/hyperactivity disorder (ADHD). The $1,047.22 firm fixed-price delivery order has an ultimate completion date of December 24, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $1,355.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566449628 units of Methylphenidate ER 27 mg tablets, a medication commonly used to treat ADHD. The award represents a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,234.15 firm fixed-price delivery order is for the supply of 54 mg tablets of the medication Methylphenidate ER, a drug used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $5,344.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract provides for the delivery of 10mg methylphenidate hydrochloride tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD) and other conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, valued at $1,361.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 100 units of Methylphenidate ER 54 mg tablets, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a completion date of December 3, 2024 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.12 firm fixed price delivery order covers the supply of 4566296303 - Methylphenidate ER 36 mg tablets, a medication used to treat ADHD. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV8Z0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,502.98 firm-fixed-price delivery order is for the supply of Methylphenidate ER 54 mg tablets, a prescription medication used to treat Attention Deficit Hyperactivity Disorder (ADHD).

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 1:27 PM